Recent Finacing
Recent Raise
Biotechnology firm developing a novel human-hormone therapy targeting age-associated muscle degradation and pathological muscle tissue changes in patients with age-related myopathy.
Focus Areas
Total Raised
Funding round
See the team members at Ally Therapeutics.
